Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesAddressing steroid phobia: Improving the risk-benefit ratio with new agents
Allergy and Asthma Proceedings, 08/28/08
Skoner JD et al. - Although some of the studies were flawed, featured drugs that are less commonly prescribed today, or both, adverse effects from chronic ICSs use are still a cause of concern today. Current therapies are designed to be efficacious at minimal doses, limiting potential side effects, increasing adherence, and improving asthma control.
| Previous Article | Next Article |
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Home use of albuterol for asthma exacerbations
Annals of Allergy, Asthma, and Immunology, 06/09/09
The Efficacy of Montelukast during the Allergy Season in Pediatric Patients with Persistent Asthma and Seasonal Aeroallergen Sensitivity
Journal of Asthma, 06/04/09
Aspirin for cardiovascular prevention in patients with diabetes
Clinical Diabetes, 06/01/09
Article Search
Sponsor